Moreover, higher mRNA expression of SLC2A5 and SLC2A12 significantly associated with worse prognosis of breast cancer patients (HR: 1.46 [1.18–1.82];p = 6E-04 and HR: 1.55 [1.12–2.14];p = 0.008, respectively). This evidence concerns the gene SLC2A5 and breast carcinoma.